Skip to content

Development of Therapeutic Technology for Periodontitis-Cardiopathy Comorbidity Based on Erythrocyte Vesicles

Development of Therapeutic Technology for Periodontitis-Cardiopathy Comorbidity Based on Erythrocyte Vesicles

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129197
Enrollment
Unknown
Registered
2026-07-31
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This study does not involve any clinical intervention. Instead, 10 mL of peripheral blood was collected from the elbow vein.

Interventions

experimental group:None

Sponsors

Peking University Hospital of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Healthy adults aged 18 and over with no blood disorders;

Exclusion criteria

Exclusion criteria: 1.Patients with or a history of hematological disorders, such as red blood cell disorders (iron deficiency anemia, aplastic anemia, thalassemia, etc.), white blood cell disorders (leukopenia, various leukemias), or platelet disorders (immune thrombocytopenia, thrombotic thrombocytopenic purpura, essential thrombocythemia, etc.); 2.patients with acute or special infections; 3.patients with benign or malignant tumors; 4.individuals with alcohol dependence, drug abuse, or other substance addictions, or those with a tendency toward addiction; 5.pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
blood routine examination;

Secondary

MeasureTime frame
Blood coagulation five items;

Countries

China

Contacts

Public ContactZhang Xiao

Peking University Hospital of Stomatology

zx8213163@163.com+86 10 82195322

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026